Table 3

Androgen receptor staining across metastatic sites for rapid autopsy (RA) cases 3, 14, 24, and 30

Metastatic tissueRA case 3RA case 14RA case 24RA case 30
Adrenal74.28 (64.4–78.93)
Bone22.66 (22.66–22.66)81.07 (75.74–86.4)
Bladder89.34 (88.54–96.65)
Dura33.59 (5.17–62.01)5.45 (1.86–9.04)
Liver46.22 (18.8–83.1)0.48 (0.41–1.78)2.28 (0.05–7.14)
Lung23.67 (15.41–27.4)0.18 (0.1–0.22)13.03 (5.64–41.95)96.89 (85.49–99.56)
Lymph node70.81 (40.78–94.65)0.06 (0.06–0.06)99.38 (99.01–99.58)
Meninges0.73 (0.64–0.81)0.01 (0–0.01)68.93 (18.31–72.12)
Prostate12.23 (3.7–13.61)1.81 (1.29–2.33)47.83 (16.3–87.04)
Soft tissue19.99 (0.49–29.08)
Testis10.7 (10.7–10.7)
  • NOTE. Median % staining of AR (range). There is one metastatic site less for cases 14 and 24 each of AR staining because of missing values. Tables 3 and 4 <$REFLINK> demonstrate heterogeneity in PSA and AR protein expression of metastatic sites in the same patient.